6 research outputs found

    O efeito da educação sobre o índice de massa corporal na população adulta brasileira

    Get PDF
    Nas Ășltimas trĂȘs dĂ©cadas houve um aumento considerĂĄvel na prevalĂȘncia de excesso de peso e a obesidade principalmente nos paĂ­ses em desenvolvimento. Dada sua associação com as doenças... (DCNT), o excesso de peso Ă© o quinto maior fator de risco por causa atribuĂ­vel, constituindo-se em um grave problema de saĂșde pĂșblica. A educação tem sido considerada um fator importante para a redução do excesso de peso e obesidade na medida em que maiores nĂ­veis de educação sĂŁo associados com menores prevalĂȘncias desses fatores de risco. Dado o aumento da obesidade no Brasil, o objetivo do presente estudo Ă© avaliar o impacto da escolaridade sobre os nĂ­veis de IMC. Tendo em vista que o efeito dos anos de escolaridade podem ser diferentes ao longo da distribuição do IMC, neste estudo um modelo de regressĂŁo QuantĂ­lica foi utilizado. Os anos de escolaridade apresentaram uma relação inversa com os nĂ­veis de IMC, o que corrobora resultados jĂĄ encontrados na literatura. Nesta monografia mostramos que este resultado Ă© bastante heterogĂȘneo ao longo da distribuição de IMC. A relação entre escolaridade e IMC Ă© particularmente mais forte nos percentis 50, 75 e 90. JĂĄ a variĂĄvel logaritmo da renda domiciliar per capita mostrou-se diretamente associada com o IMC, com efeitos semelhantes em todos os percentis. HĂĄ evidĂȘncias de impactos diferenciados da educação e renda segundo o sexo, mas isso deve ser analisado em maior profundidade

    Kidney function in tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis users: a systematic review and meta-analysis of published literature and a multi-country meta-analysis of individual participant data

    Get PDF
    BACKGROUND: Previous WHO guidance on tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis (PrEP) suggests measuring creatinine levels at PrEP initiation and regularly afterwards, which might represent barriers to PrEP implementation and uptake. We aimed to systematically review published literature on kidney toxicity among tenofovir disoproxil fumarate-based oral PrEP users and conducted an individual participant data meta-analysis (IPDMA) on kidney function among PrEP users in a global implementation project dataset. METHODS: In this systematic review and meta-analysis we searched PubMed up to June 30, 2021, for randomised controlled trials (RCTs) or cohort studies that reported on graded kidney-related adverse events among oral PrEP users (tenofovir disoproxil fumarate-based PrEP alone or in combination with emtricitabine or lamivudine). We extracted summary data and conducted meta-analyses with random-effects models to estimate relative risks of grade 1 and higher and grade 2 and higher kidney-related adverse events, measured by elevated serum creatinine or decline in estimated creatinine clearance or estimated glomerular filtration rate. The IPDMA included (largely unpublished) individual participant data from 17 PrEP implementation projects and two RCTs. Estimated baseline creatinine clearance and creatinine clearance change after initiation were described by age, gender, and comorbidities. We used random-effects regressions to estimate the risk in decline of creatinine clearance to less than 60 mL/min. FINDINGS: We identified 62 unique records and included 17 articles reporting on 11 RCTs with 13 523 participants in meta-analyses. PrEP use was associated with increased risk of grade 1 and higher kidney adverse events (pooled odds ratio [OR] 1·49, 95% CI 1·22-1·81; I2=25%) and grade 2 and higher events (OR 1·75, 0·68-4·49; I2=0%), although the grade 2 and higher association was not statistically significant and events were rare (13 out of 6764 in the intervention group vs six out of 6782 in the control group). The IPDMA included 18 676 individuals from 15 countries (1453 [7·8%] from RCTs) and 79 (0·42%) had a baseline estimated creatinine clearance of less than 60 mL/min (increasing proportions with increasing age). Longitudinal analyses included 14 368 PrEP users and 349 (2·43%) individuals had a decline to less than 60 mL/min creatinine clearance, with higher risks associated with increasing age and baseline creatinine clearance of 60·00-89·99 mL/min (adjusted hazard ratio [aHR] 8·49, 95% CI 6·44-11·20) and less than 60 mL/min (aHR 20·83, 12·83-33·82). INTERPRETATION: RCTs suggest that risks of kidney-related adverse events among tenofovir disoproxil fumarate-based oral PrEP users are increased but generally mild and small. Our global PrEP user analysis found varying risks by age and baseline creatinine clearance. Kidney function screening and monitoring might focus on older individuals, those with baseline creatinine clearance of less than 90 mL/min, and those with kidney-related comorbidities. Less frequent or optional screening among younger individuals without kidney-related comorbidities may reduce barriers to PrEP implementation and use. FUNDING: Unitaid, Bill & Melinda Gates Foundation, WHO

    INFECÇÕES SEXUALMENTE TRANSMISSÍVEIS (IST) ENTRE HOMENS QUE FAZEM SEXO COM HOMENS (HSH), TRAVESTIS E MULHERES TRANS (TMT) EM USO DE PROFILAXIA PRÉ-EXPOSIÇÃO PARA HIV (PREP) NO BRASIL

    No full text
    Introdução: A incorporação da PrEP como polĂ­tica de saĂșde pĂșblica ampliou a testagem de IST no Brasil. O paĂ­s Ă© um dos mais afetados pela sĂ­filis a nĂ­vel global, no entanto carece de dados populacionais sobre clamĂ­dia (CT) e gonorreia (NG). O ImPrEP foi um estudo que avaliou a implementação da PrEP no Brasil, MĂ©xico e Peru. No Brasil, incluiu 3.928 HSH e TMT. O objetivo desse trabalho Ă© explorar dados relacionados Ă s vulnerabilidades para IST no Brasil entre participantes acompanhados no ImPrEP. MĂ©todos: De 2018 a 2020, incluĂ­mos HSH e TMT ≄ 18 anos, com seguimento atĂ© 2021. Exames para IST bacterianas foram coletados na inclusĂŁo e trimestralmente (sĂ­filis) ou anualmente (CT/NG). Consideramos todos os participantes do ImPrEP no Brasil com realização de pelo menos um exame para qualquer IST bacteriana (sĂ­filis, CT/NG) durante o estudo. Realizamos anĂĄlise descritiva das frequĂȘncias de IST por unidade federativa (UF) e das caracterĂ­sticas sociodemogrĂĄficas e comportamentais dos participantes. Resultados: IncluĂ­mos 3.478 participantes de 8 UF de todas as regiĂ”es do paĂ­s, com maior concentração no Rio de Janeiro (RJ) (30%) e SĂŁo Paulo (SP) (27%). Desses, 25% tinham 18-24 anos, 51% eram nĂŁo brancos, 80% com escolaridade pĂłs-secundĂĄria, 96% HSH e 4% TMT. Na inclusĂŁo, a prevalĂȘncia de sĂ­filis foi maior no Distrito Federal (DF) (17%) e no Amazonas (AM) (15.6%), enquanto CT/NG nĂŁo apresentaram diferenças significativas entre UF. Maior incidĂȘncia de sĂ­filis foi identificada em Santa Catarina (SC) (15.8/100 pessoas-ano), DF (14.8/100 pessoas-ano) e Bahia (BA) (13.5/100 pessoas-ano). ApĂłs iniciar PrEP, 35% dos participantes foram diagnosticados com alguma IST bacteriana, sem associação com a UF de origem. Em SC, participantes reportaram mais frequentemente mĂșltiplas parcerias sexuais (53%), no entanto menos relaçÔes anais receptivas sem uso de preservativo (39%). O uso excessivo de ĂĄlcool foi mais frequente em AM (82%) e BA (80%), enquanto o uso de drogas estimulantes ocorreu mais no DF (35%), SP (24%) e RJ (18%). ConclusĂŁo: Nossos achados contribuem para caracterização da prevalĂȘncia de IST entre usuĂĄrios de PrEP de diferentes estados brasileiros, trazendo dados inĂ©ditos sobre infecção por CT/NG nessa população. Considerando a diversidade territorial e cultural do Brasil, vulnerabilidades distintas podem estar envolvidas na dinĂąmica de transmissĂŁo de IST, e a implementação de polĂ­ticas pĂșblicas de prevenção para o HIV e IST deve ser adaptada Ă s realidades locais

    Kidney function in tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis users: a systematic review and meta-analysis of published literature and a multi-country meta-analysis of individual participant data

    No full text
    Background: Previous WHO guidance on tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis (PrEP) suggests measuring creatinine levels at PrEP initiation and regularly afterwards, which might represent barriers to PrEP implementation and uptake. We aimed to systematically review published literature on kidney toxicity among tenofovir disoproxil fumarate-based oral PrEP users and conducted an individual participant data meta-analysis (IPDMA) on kidney function among PrEP users in a global implementation project dataset. Methods: In this systematic review and meta-analysis we searched PubMed up to June 30, 2021, for randomised controlled trials (RCTs) or cohort studies that reported on graded kidney-related adverse events among oral PrEP users (tenofovir disoproxil fumarate-based PrEP alone or in combination with emtricitabine or lamivudine). We extracted summary data and conducted meta-analyses with random-effects models to estimate relative risks of grade 1 and higher and grade 2 and higher kidney-related adverse events, measured by elevated serum creatinine or decline in estimated creatinine clearance or estimated glomerular filtration rate. The IPDMA included (largely unpublished) individual participant data from 17 PrEP implementation projects and two RCTs. Estimated baseline creatinine clearance and creatinine clearance change after initiation were described by age, gender, and comorbidities. We used random-effects regressions to estimate the risk in decline of creatinine clearance to less than 60 mL/min. Findings: We identified 62 unique records and included 17 articles reporting on 11 RCTs with 13 523 participants in meta-analyses. PrEP use was associated with increased risk of grade 1 and higher kidney adverse events (pooled odds ratio [OR] 1·49, 95% CI 1·22–1·81; I2=25%) and grade 2 and higher events (OR 1·75, 0·68–4·49; I2=0%), although the grade 2 and higher association was not statistically significant and events were rare (13 out of 6764 in the intervention group vs six out of 6782 in the control group). The IPDMA included 18 676 individuals from 15 countries (1453 [7·8%] from RCTs) and 79 (0·42%) had a baseline estimated creatinine clearance of less than 60 mL/min (increasing proportions with increasing age). Longitudinal analyses included 14 368 PrEP users and 349 (2·43%) individuals had a decline to less than 60 mL/min creatinine clearance, with higher risks associated with increasing age and baseline creatinine clearance of 60·00–89·99 mL/min (adjusted hazard ratio [aHR] 8·49, 95% CI 6·44–11·20) and less than 60 mL/min (aHR 20·83, 12·83–33·82). Interpretation: RCTs suggest that risks of kidney-related adverse events among tenofovir disoproxil fumarate-based oral PrEP users are increased but generally mild and small. Our global PrEP user analysis found varying risks by age and baseline creatinine clearance. Kidney function screening and monitoring might focus on older individuals, those with baseline creatinine clearance of less than 90 mL/min, and those with kidney-related comorbidities. Less frequent or optional screening among younger individuals without kidney-related comorbidities may reduce barriers to PrEP implementation and use. Funding: Unitaid, Bill & Melinda Gates Foundation, WHO

    Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

    Get PDF
    Background Anastomotic leak affects 8 per cent of patients after right colectomy with a 10-fold increased risk of postoperative death. The EAGLE study aimed to develop and test whether an international, standardized quality improvement intervention could reduce anastomotic leaks. Methods The internationally intended protocol, iteratively co-developed by a multistage Delphi process, comprised an online educational module introducing risk stratification, an intraoperative checklist, and harmonized surgical techniques. Clusters (hospital teams) were randomized to one of three arms with varied sequences of intervention/data collection by a derived stepped-wedge batch design (at least 18 hospital teams per batch). Patients were blinded to the study allocation. Low- and middle-income country enrolment was encouraged. The primary outcome (assessed by intention to treat) was anastomotic leak rate, and subgroup analyses by module completion (at least 80 per cent of surgeons, high engagement; less than 50 per cent, low engagement) were preplanned. Results A total 355 hospital teams registered, with 332 from 64 countries (39.2 per cent low and middle income) included in the final analysis. The online modules were completed by half of the surgeons (2143 of 4411). The primary analysis included 3039 of the 3268 patients recruited (206 patients had no anastomosis and 23 were lost to follow-up), with anastomotic leaks arising before and after the intervention in 10.1 and 9.6 per cent respectively (adjusted OR 0.87, 95 per cent c.i. 0.59 to 1.30; P = 0.498). The proportion of surgeons completing the educational modules was an influence: the leak rate decreased from 12.2 per cent (61 of 500) before intervention to 5.1 per cent (24 of 473) after intervention in high-engagement centres (adjusted OR 0.36, 0.20 to 0.64; P < 0.001), but this was not observed in low-engagement hospitals (8.3 per cent (59 of 714) and 13.8 per cent (61 of 443) respectively; adjusted OR 2.09, 1.31 to 3.31). Conclusion Completion of globally available digital training by engaged teams can alter anastomotic leak rates. Registration number: NCT04270721 (http://www.clinicaltrials.gov)
    corecore